Morfex

Quick links to important sections

Morfex

Selected form

Method of action: Anxiolytic, Hypnotic, Psycholeptics

Treatment option: Insomnia

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Morfex

Quick Facts

Property Description
Active ingredient Flurazepam Hydrochloride
Form Capsule
Pharmacological class Benzodiazepine, Sedative/Hypnotic
General purpose To promote sleep and induce sedation
Origin Synthetic

What Type of Medicine is Morfex (Flurazepam Hydrochloride)?

Morfex is a pharmaceutical preparation identified by the active ingredient Flurazepam Hydrochloride. This substance is a synthetic compound that belongs to the benzodiazepine pharmacological class, chemically defined by the 1,4-benzodiazepinone structure. The drug functions primarily as a potent Central Nervous System (CNS) depressant, which reduces overall nervous activity. Morfex is specifically classified as a long-acting benzodiazepine because its primary active metabolite, N-desalkylflurazepam, maintains activity for an extended period, which differentiates its duration of effect from shorter-acting alternatives.

Composition and Pharmaceutical Form of Morfex

The Morfex product is a single-ingredient product (monocomponent) that is manufactured in the capsule dosage form and designed for administration via the Oral Route. The capsule contains the sole active agent, Flurazepam Hydrochloride, alongside essential pharmaceutical excipients (inactive ingredients) required for stability and proper delivery. Due to its classification, Morfex is universally designated as a prescription-only medication, indicating specific controls required for its distribution.

General Purpose: Morfex as a Sedative/Hypnotic Agent

The general purpose of Morfex is to produce a strong state of sedation and a calming effect by enhancing the action of the brain's main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). This action slows down excessive or racing brain activity. Flurazepam is classified as a hypnotic and sedative agent. This confirms that the drug's core utility is focused on facilitating the necessary physiological shift to help individuals successfully initiate and maintain sleep continuity.

What side effects are possible with Morfex?

Morfex: Official Side Effects and Safety Characteristics

This section describes the adverse reactions and safety characteristics of Morfex (Flurazepam Hydrochloride) as officially documented in regulatory sources.


Adverse Reaction Scope

Classification Documented Effects
Common Reactions Drowsiness, dizziness, light-headedness, staggering, loss of coordination, and falling are the most frequently observed effects, particularly noted in older or debilitated individuals.
System-Organ Classes Effects primarily involve the Nervous System (including psychiatric disturbances), Gastrointestinal System, and less commonly, Dermatological and Blood/Lymphatic Systems.
Rare Reactions Rarely documented effects include blood disorders such as leukopenia and granulocytopenia, as well as paradoxical reactions like excitement or hyperactivity.

Serious Adverse Reactions

Official labeling highlights the potential for serious adverse reactions. These include the occurrence of complex sleep-related behaviors (such as sleep-driving) and very rare but severe anaphylactic or anaphylactoid reactions (e.g., angioedema). There is also a documented risk of respiratory depression, especially when the medicine is used concurrently with opioids or other Central Nervous System depressants, and the risk of abuse, misuse, and addiction.


Safety Patterns and Constraints

The safety profile is time-dependent. Prolonged or continuous use is associated with the risk of developing tolerance and physical dependence. Abrupt cessation can lead to rebound insomnia (intensified return of sleep difficulty) and withdrawal symptoms. Regulatory documents define several safety constraints, noting the drug is contraindicated in patients with a known hypersensitivity to benzodiazepines, severe respiratory insufficiency (including sleep apnea syndrome), myasthenia gravis, and severe hepatic insufficiency. Special considerations are explicitly defined for older adults due to their increased risk of sedation and falling, and for pregnancy due to potential fetal harm.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation strictly classifies Morfex (Flurazepam Hydrochloride) overdose as a profound Central Nervous System (CNS) depression event that requires immediate emergency response.

Domain Official Regulatory Statements
Clinical Manifestations Overdose symptoms are characterized by progressing levels of CNS impairment, including somnolence (drowsiness), confusion, lethargy, and impaired coordination (ataxia).
Life-Threatening Risks Severe outcomes documented in official labeling include coma, significant respiratory depression, and severe hypotension. Fatal outcome is a recognized risk, especially when the drug is taken with alcohol or other CNS depressants.
Mandatory Emergency Action Seek immediate medical attention and contact emergency services or a certified Poison Control Center for all suspected exposures. Treatment is primarily symptomatic and supportive.
Monitoring and Antidote Prolonged observation is required due to the persistent action of the metabolite, N-desalkylflurazepam. The antagonist Flumazenil is cited, but with an explicit caution about the risk of precipitating seizures.
Special Population Note Increased severity of toxic effects is explicitly recognized in the elderly or debilitated patient.

All suspected cases require urgent hospital monitoring and continuous cardiac assessment. The official overdose profile mandates that because of the potential for severe respiratory and hemodynamic compromise, a detailed medical assessment is necessary to ensure the maintenance of vital function and proper supportive care as defined by the regulatory authorities.

Therapeutic Uses of Morfex

Morfex (Flurazepam) is a dedicated hypnotic agent commonly used to provide symptomatic support across the complex manifestations of sleep deprivation, applied in contexts where additional symptomatic support is needed. Its utility is centered on short-term assistance for sleep failure, addressing key symptom clusters associated with impaired restful sleep.

The medication helps address symptom clusters that may become intense or disruptive, including difficulty initiating sleep, frequent nocturnal awakenings, and premature waking in the early morning. It is utilized in conditions characterized by periods of heightened symptoms, specifically short-term or transient insomnia.

“The therapeutic aim is centered on easing the symptomatic discomfort that prevents patients from sleeping continuously.”

Morfex is commonly applied in scenarios requiring temporary symptomatic support, such as those associated with situational stress or acute interruptions to routines. It is considered relevant when symptoms are mild to moderate but create noticeable interference with daily stability. The medication may assist with a transition toward more continuous sleep and contributes to supporting a more restful sleep period, which assists with maintaining functional stability.


Quick Fact: Relief for Sleep Maintenance This medication is often employed when the primary issue involves difficulty staying asleep throughout the night and waking too early, contributing supportive relief that covers the duration of a typical night's sleep.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Morfex?

Eligibility to use Morfex (Flurazepam Hydrochloride) is determined strictly by regulatory guidelines based on age, physiological status, and pre-existing medical conditions.


Populations Excluded from Use

Morfex is formally contraindicated in several populations:

  • Patients with a known hypersensitivity or severe allergic reaction to flurazepam or other benzodiazepines.
  • Individuals who have experienced angioedema (severe swelling of the face, tongue, or throat) following use of the drug.
  • Pregnant women due to documented potential for fetal harm (categorized as Pregnancy Category X by some authorities).
  • Patients with myasthenia gravis or severe respiratory insufficiency, including diagnosed sleep apnea syndrome.

Age and Conditional Restrictions

  • Children and Adolescents: The drug is not recommended for use in persons under 15 years of age because safety and effectiveness have not been established in this population.
  • Older Adults (Geriatric): Use requires special caution due to increased sensitivity to sedative effects and a higher risk of adverse reactions, such as confusion and dizziness.
  • Organ Function: Use requires caution in patients with impaired renal (kidney) or hepatic (liver) function, and severe hepatic impairment is a contraindication.
  • Lactating Women: Use is not recommended as the drug and its metabolites are excreted in human milk, potentially causing sedation in the infant.

What should I know about interactions with other medicines?

Morfex (morphine sulfate) interactions with other medicinal products are primarily pharmacodynamic, leading to enhanced effects on the central nervous system (CNS) and serious safety risks.

Contraindicated and High-Risk Combinations

Product Category Interaction Mechanism Clinical Risk and Classification
Monoamine Oxidase Inhibitors (MAOIs) Serotonin Syndrome and Opioid Toxicity. Contraindicated: Use is prohibited within 14 days of taking MAOIs (e.g., phenelzine, linezolid) due to risk of coma, respiratory depression, and severe toxicity.
CNS Depressants (e.g., Benzodiazepines, Alcohol) Additive CNS Depression. High-Risk/Boxed Warning: Concomitant use should be limited as it can result in profound sedation, severe respiratory depression, coma, and death. Dosage and duration must be minimized.
Mixed Agonist/Antagonist Opioids Receptor Competition/Partial Antagonism. Avoid: Co-administration may reduce the analgesic effect of Morfex or precipitate symptoms of withdrawal in physically dependent patients.

Other Documented Interactions

Concomitant use with Serotonergic Drugs (e.g., SSRIs, SNRIs, tricyclic antidepressants) may lead to Serotonin Syndrome, a potentially life-threatening condition requiring immediate discontinuation of Morfex if suspected. Caution is also advised with Muscle Relaxants, as Morfex may enhance the neuromuscular blocking effects, increasing the risk of respiratory depression.

Mechanism of Action

How Morfex Works

Morfex is a pharmacological agent designed to exert its action by precisely engaging and modulating specific biological pathways. Its pharmacodynamic effect is characterized primarily by the regulation of receptor- and enzyme-mediated signaling to modulate activity in overactive physiological processes.


Modulation of Specific Receptor-Mediated Signaling

Morfex acts within domains of receptor-mediated signaling by initiating or suppressing the early molecular steps that shape systemic physiological consequences. This intervention influences the establishment of a modulated signaling state within targeted pathways, which results in reduced downstream signaling from excessive mediator activity that drives dysregulated cellular processes.


Targeted Enzyme Pathway Adjustment

The drug engages mechanisms that regulate these overactive processes by affecting cellular systems where specific transmitters or mediators dominate. Morfex modifies key pathways associated with heightened physiological responses, leading to predictable physiological adjustments by influencing the rate and magnitude of signaling within these enzymatic cascades. The result is a sustained adjustment to the targeted pathway activity.

Dosage and Administration Information

Morfex is administered orally as a capsule, taken once daily at the time of retiring to bed, not sooner. The lowest possible effective dose should always be utilized to initiate treatment.


Official Dosing Regimens

The standard adult dosage for Morfex ranges from 15 mg to 30 mg per day. A differentiated initial approach is specified: 15 mg is the recommended starting dose for adult women, while adult men may begin with either 15 mg or 30 mg. This difference is based on the observed clearance rate of the active metabolite.


Usage in Specific Populations

For older adults or debilitated patients, the initial dose and subsequent dosage should be limited to a maximum of 15 mg due to increased sensitivity to dose-related effects. Dose reduction is also required for patients with known hepatic or renal impairment. The medicine is not recommended for use in the pediatric population.


Duration and Administration Protocol

Morfex is intended for short-term use, with the total treatment duration typically limited to a maximum of four weeks, which includes the mandatory period of dose reduction. Upon discontinuation, the dosage must be gradually reduced (tapered) according to a physician's schedule. If a dose is missed at bedtime, the guidance is to skip the forgotten dose and not take a double dose to compensate.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Morfex

Evidence for Use in Short-Term Insomnia Symptoms

The research base for Morfex (Flurazepam Hydrochloride) was studied for use in acute or short-term insomnia. The primary evidence base consists of short-term, randomized, controlled trials (RCTs), often comparing the medication against an inactive placebo. Some studies explored comparisons against other medications. Researchers in these settings used precise measurements, including objective polysomnography (PSG) conducted in sleep laboratories, which was used to objectively monitor certain aspects of sleep. They also relied on patient-reported outcomes describing perceived discomfort and difficulties.

The research was designed to examine two key outcomes related to systemic or functional imbalance: the time it took participants to fall asleep (Sleep Latency) and the ability to remain asleep throughout the night (Wake After Sleep Onset, or WASO). Findings describe patterns observed in the studies related to measured differences in these sleep parameters between groups receiving the drug and those receiving placebo.

  • Outcomes Studied in Short-Term Trials

Specifically, researchers monitored for any lingering effects or impairment, particularly on functional measures, such as reaction time and coordination tasks. Regulatory documents consistently reported data show patterns related to residual activity and impaired performance on these psychomotor tasks the morning after the dose.

Study Duration: Short-Term vs. Long-Term Data

The most substantial and consistent evidence for Morfex was observed in controlled clinical trials focused on short-term differences in sleep measures, usually over a period of up to four weeks. Follow-up durations were limited, and high-quality, continuous efficacy data derived from controlled trials data are still emerging for periods exceeding four to six weeks. The limited controlled, long-term evidence indicates that long-term outcomes are not fully established.

Evidence in Specific Populations

Most of the early controlled clinical evidence was studied for the general adult population. Specific trials studies explored the effects in the older adult (geriatric) population. Studies were conducted to specifically evaluate differences in the observed effects in this age group. However, data for certain groups remain insufficient, including evidence for children, adolescents, or patients with various complex co-occurring medical conditions.

What Research Gaps and Uncertainties Remain

The evidence base, while defined by short-term RCTs, contains several areas of remaining uncertainty. Evidence quality varies across studies, and the follow-up durations were limited in many of the key efficacy trials. The persistent finding of next-day residual activity suggests the research highlights a functional pattern that was associated with the medication in the studies. Finally, subgroup findings are uncertain due to limited data for many patient profiles outside the general adult and geriatric populations studied.

Key Studies & References WHO Model List of Essential Medicines (Flurazepam Classification and Use)

Frequently Asked Questions (FAQ)

Common questions about Morfex (FAQ)

Q: How quickly can someone expect to feel the effects of Morfex?

Official product information indicates that the hypnotic, or sleep-inducing, effect typically begins within 15 to 45 minutes after the dose is taken. This rapid onset is consistent with the drug’s intended purpose.


Q: Can I take Morfex if I am already taking over-the-counter pain relievers?

The regulatory label does not specifically list common over-the-counter (OTC) pain relievers as formal interactions. However, the official guidance emphasizes informing your healthcare provider about all OTC medicines and supplements you are currently using, as there is always a potential for unintended interactions.


Q: Are there any specific foods or drinks to avoid when using Morfex?

According to official drug information, there are no known interactions between Morfex and most common foods or drinks. The primary restriction noted in regulatory documents is that alcohol should be avoided due to the risk of profound additive central nervous system (CNS) depression.


Q: Does Morfex interact with herbal supplements like St. John's Wort?

The official drug label lists interactions with various drug classes and compounds that affect certain liver enzymes. Because herbal products can also influence these metabolic processes, there is a possibility of unintended interaction. Official guidance emphasizes informing your healthcare provider about all herbal supplements you use to facilitate safe treatment management.


Q: Can Morfex affect fertility?

Regulatory documents do not explicitly state an effect on fertility itself, although studies have been conducted in animals. For women who are pregnant, the medicine is formally contraindicated due to the documented potential for fetal harm.


Q: Is there a generic version of Morfex available?

Yes, the active ingredient in Morfex, Flurazepam Hydrochloride, is available in a generic formulation. Generic medicines contain the exact same active ingredient and meet the same regulatory standards for quality and efficacy as their brand-name counterparts.


Q: What is the half-life of Morfex?

Morfex is known to be a long-acting benzodiazepine. While the parent drug is eliminated quickly, its main active metabolite (N-1-Desalkylflurazepam) has a very prolonged elimination half-life, which can typically range from 47 to over 100 hours.


Q: Can Morfex interfere with birth control pills?

Official documentation advises caution when Morfex is used at the same time as hormonal contraceptives, such as birth control pills. This combination may slow down the body's natural process for breaking down the benzodiazepine, which could potentially lead to increased effects or toxicity.


Q: How does Morfex affect blood pressure?

Blood pressure effects are primarily noted in the context of taking too much medicine. Official information states that hypotension (low blood pressure) is a potential symptom that may occur in cases of accidental overdose. Official guidance states that blood pressure is a parameter to be monitored in an overdose scenario.


Q: Does Morfex require any special monitoring or blood tests?

While specialized therapeutic drug monitoring is available for benzodiazepines, the official label primarily advises regular monitoring for the medicine's effectiveness and any adverse effects. The determination of need for specific tests is made by your healthcare provider based on your overall health.


Q: Are there different brand names for the medicine Morfex?

Yes, the medication with the active ingredient Flurazepam Hydrochloride has been historically marketed under the brand name Dalmane. Morfex is one of the names associated with the drug.


Q: Does taking Morfex with food change how it works?

Official drug information does not list any known interactions between Morfex and common foods. However, the label strongly cautions that the effect of the drug can be significantly enhanced by the use of alcohol, which should be avoided.


Q: Does Morfex interact with cold or flu medications?

Morfex has documented major interactions with other Central Nervous System (CNS) depressants. Because many common cold and flu medicines contain ingredients like antihistamines that cause drowsiness, using them concurrently requires caution due to the risk of increased sedation.


Q: What happens if a person accidentally takes too much Morfex?

Overdose symptoms may include increasing levels of CNS depression, such as drowsiness, confusion, and slurred speech. In serious cases, it can lead to weak or shallow breathing, or even coma. Regulatory documents indicate that emergency medical attention is necessary if an overdose is suspected, especially if alcohol or opioids were also taken.


Q: How is Morfex different from similar medicines I see advertised?

Morfex is factually classified as a long-acting benzodiazepine. This classification is due to its main active metabolite having a prolonged half-life, meaning its effects and metabolites remain active in the body for a relatively extended period compared to shorter-acting alternatives.


Q: Does Morfex build up in the body over time?

Yes, official pharmacokinetic data indicates that its major active metabolite has a prolonged half-life, potentially lasting up to 100 hours or more. This long half-life means that the metabolite will accumulate in the bloodstream when repeated daily doses are taken, until a consistent concentration is reached.


Q: Are the clinical trials for Morfex finished, and where can I find the results?

The initial clinical trials required by health authorities for the drug's approval are complete, and this information is contained within the official Prescribing Information. For current and publicly available information on drug studies, official government resources like ClinicalTrials.gov may contain further data.


Q: I've heard people call Morfex a 'miracle drug'—is there evidence for that?

Official documentation reports the drug's effectiveness in improving objective measurements of sleep, such as the time it takes to fall asleep (sleep latency) and reducing the number of nocturnal awakenings. Regulatory sources do not use subjective or promotional terms like 'miracle drug' to describe any medicine.


Q: Does Morfex need to be taken at the same time every day?

The product should be taken once daily just before going to bed. To help ensure predictable results and maintain consistent levels of the medication in the body, it is generally recognized that maintaining a consistent dosing schedule may be helpful.


Q: Is there a warning about Morfex and driving/operating machinery?

Official warnings and precautions advise that the drug can cause impaired alertness and coordination that may carry over into the next day. Regulatory documents indicate that patients should be cautioned against driving and performing other tasks that require complete mental alertness.


Q: Why does Morfex have a Black Box Warning, if it does?

The FDA requires a Boxed Warning for all benzodiazepine medicines, including Morfex. This serious warning describes the risks of abuse, misuse, addiction, physical dependence, and potentially severe withdrawal reactions if the medicine is abruptly discontinued.


Q: What is the status of ongoing research into Morfex?

The most substantial and consistent evidence supports Morfex for short-term use. High-quality, continuous efficacy and safety data derived from controlled trials for use over longer periods (exceeding four to six weeks) is still considered limited and is an area where evidence is still emerging.


Q: What are the long-term effects of Morfex on the body?

Official documentation states that prolonged or continuous use is associated with the risk of developing tolerance and physical dependence. Due to these risks, regulatory documents define the drug as only being approved for short-term use, typically limited to a maximum of four weeks.


Q: Is the efficacy of Morfex supported by multiple large-scale studies?

The drug's efficacy is supported by results from short-term, randomized, controlled trials (RCTs) used for regulatory approval. While the evidence is defined by these studies, official sources note that the evidence quality for specific patient groups and for long-term use remains limited.

How should Morfex be stored and disposed of?

Storage and Disposal Requirements for Morfex (Flurazepam Hydrochloride)

Morfex is a controlled substance that must be stored and disposed of according to strict regulatory guidelines to prevent misuse and accidental ingestion.


Storage Conditions

  • Temperature Control: Store capsules at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F). Freezing temperatures must be avoided.
  • Protection: The medicine must be protected from moisture and kept in its tightly closed, original container.
  • Child Safety: Due to its potential for harm, Morfex must be stored securely and out of the sight and reach of children.

Disposal Instructions

Unused or expired Morfex should be discarded through an authorized drug take-back program. If this option is not available, the product may be mixed with an undesirable substance (e.g., used coffee grounds) and sealed in a plastic bag before being placed in household trash. It must not be flushed down a toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Morfex found in:

A-Z Index: